Admission to Trading Application

Summary by AI BETAClose X

Oxford Biomedica PLC has applied to the London Stock Exchange for the admission to trading of 7,363 ordinary shares of 50 pence each, which have been allotted under the OXB Deferred Bonus Plan and the OXB Sharesave Scheme. These new ordinary shares are expected to be admitted to trading on 14 August 2026 and will rank equally with existing shares.

Disclaimer*

UK 100

Latest directors dealings